Retatrutide's glucagon receptor component adds a thermogenic and lipolytic action that preferentially targets visceral fat
Research indicates that rapid weight loss from any causeincluding pharmacotherapycan result in loss of both fat and muscle tissue
3 While other diabetic treatment options exist, including low carbohydrate diets, physical activity, and other medication options, GLP1 receptor agonists can serve as a powerful tool for diabetic management in individuals who have been unable to achieve desired glycemic control using such options
Some patients mention that reducing their intake of carbohydrates (rice, pasta, bread) and increasing their intake of high protein food reduces their side effects
These gains stem from enhanced energy-cell function and oxidant body function
In summary, a well-executed Clinical Trial in Korea can accelerate development timelines and provide globally credible results at lower cost an appealing proposition for European sponsors in 2026